AU2002224113A1 - Paramyxovirus vector encoding angiogenesis gene and utilization thereof - Google Patents
Paramyxovirus vector encoding angiogenesis gene and utilization thereofInfo
- Publication number
- AU2002224113A1 AU2002224113A1 AU2002224113A AU2411302A AU2002224113A1 AU 2002224113 A1 AU2002224113 A1 AU 2002224113A1 AU 2002224113 A AU2002224113 A AU 2002224113A AU 2411302 A AU2411302 A AU 2411302A AU 2002224113 A1 AU2002224113 A1 AU 2002224113A1
- Authority
- AU
- Australia
- Prior art keywords
- utilization
- vector encoding
- angiogenic genes
- paramyxovirus vector
- angiogenesis gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 239000013598 vector Substances 0.000 title abstract 4
- 230000033115 angiogenesis Effects 0.000 title 1
- 230000002491 angiogenic effect Effects 0.000 abstract 3
- 230000000302 ischemic effect Effects 0.000 abstract 2
- 101150019331 FGF2 gene Proteins 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18841—Use of virus, viral particle or viral elements as a vector
- C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-359374 | 2000-11-27 | ||
JP2000359374 | 2000-11-27 | ||
PCT/JP2001/010323 WO2002042481A1 (fr) | 2000-11-27 | 2001-11-27 | Vecteur paramyxovirus codant pour un gene d'angiogenese et son utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002224113A1 true AU2002224113A1 (en) | 2002-06-03 |
Family
ID=18831146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002224113A Abandoned AU2002224113A1 (en) | 2000-11-27 | 2001-11-27 | Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
Country Status (12)
Country | Link |
---|---|
US (3) | US20040005296A1 (da) |
EP (1) | EP1344829B1 (da) |
JP (1) | JP4212357B2 (da) |
KR (1) | KR100812884B1 (da) |
CN (1) | CN100357443C (da) |
AT (1) | ATE393235T1 (da) |
AU (1) | AU2002224113A1 (da) |
CA (1) | CA2430112C (da) |
DE (1) | DE60133767T2 (da) |
DK (1) | DK1344829T3 (da) |
ES (1) | ES2305138T3 (da) |
WO (1) | WO2002042481A1 (da) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1143892C (zh) * | 1995-11-01 | 2004-03-31 | 株式会社载体研究所 | 重组仙台病毒 |
ES2326101T3 (es) * | 1998-07-03 | 2009-09-30 | Dnavec Research Inc. | Vector de virus arn cadena (-) para celulas nerviosas. |
US6490775B1 (en) * | 1999-04-23 | 2002-12-10 | Veri-Tek Inc. | Press operation verification system |
US7226786B2 (en) * | 1999-05-18 | 2007-06-05 | Dnavec Research Inc. | Envelope gene-deficient Paramyxovirus vector |
US20030166252A1 (en) * | 1999-05-18 | 2003-09-04 | Kaio Kitazato | Paramyxovirus-derived RNP |
DK1211318T3 (da) * | 1999-09-06 | 2007-11-12 | Dnavec Research Inc | Paramyxovira omfattende en modificeret transkriptionsstartsekvens |
US7314614B1 (en) | 1999-11-02 | 2008-01-01 | Dnavec Research, Inc. | Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
EP1270016A4 (en) | 2000-03-30 | 2005-10-19 | Dnavec Research Inc | VACCINE AGAINST AIDS VIRUS CONTAINING A VECTOR OF SENDAI VIRUS |
CA2413995C (en) * | 2000-06-01 | 2013-08-13 | Dnavec Research Inc. | Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity |
EP1297852A4 (en) * | 2000-06-27 | 2004-12-29 | Dnavec Research Inc | VIRAL VECTOR FOR THE INTRODUCTION OF GENES IN KIDNEY CELLS (03.02.03) |
JP2002142770A (ja) * | 2000-11-08 | 2002-05-21 | Dnavec Research Inc | 循環系への遺伝子送達用パラミクソウイルスベクター |
AU2002224113A1 (en) * | 2000-11-27 | 2002-06-03 | Dnavec Research Inc. | Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
JPWO2003092738A1 (ja) * | 2002-04-30 | 2005-09-08 | 株式会社ディナベック研究所 | ヘマグルチニン活性を低下させた薬剤または遺伝子運搬組成物 |
AU2003261931A1 (en) * | 2002-09-04 | 2004-03-29 | Dnavec Research Inc. | Process for producing virus vector containing membrane protein having sialic acid-binding activitiy in envelope with the use of gram-positive bacterium-origin neuraminidase |
CA2503317A1 (en) * | 2002-10-24 | 2004-05-06 | Dnavec Research Inc. | Method of transferring gene into t cells |
EP1642966B1 (en) * | 2003-06-30 | 2010-03-03 | Dnavec Research Inc. | Minus strand rna viral vectors carrying a gene with altered hypermutable regions |
DE10333217A1 (de) * | 2003-07-22 | 2005-03-10 | Biomay Prod & Handel | Polypeptide, hierfür kodierende Nucleinsäuren aus dem Schimmelpilz Cladosporium herbarum sowie deren Herstellung und Verwendung in Diagnostik und Therapie |
EP1715048A4 (en) * | 2004-01-22 | 2007-02-07 | Dnavec Research Inc | PROCESS FOR PRODUCING A VIRAL VECTOR |
CN1957084A (zh) * | 2004-03-23 | 2007-05-02 | 株式会社载体研究所 | 与组织的维持和/或修复相关联的骨髓相关细胞 |
EP2993235B1 (en) | 2005-10-28 | 2019-02-13 | ID Pharma Co., Ltd. | Gene transfer into airway epithelial stem cell by using simian lentiviral vector pseudotyped with sendai rna virus spike protein |
KR101336386B1 (ko) * | 2011-06-17 | 2013-12-04 | 전북대학교병원 | 림프관 생성 유도제 |
CA3176712A1 (en) | 2013-03-15 | 2014-09-18 | Elixirgen Therapeutics, Inc. | Methods of using zscan4 for rejunevating human cells |
MY187966A (en) * | 2013-04-26 | 2021-11-02 | Genomatica Inc | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
US20160312261A1 (en) * | 2015-04-24 | 2016-10-27 | Plasmia Biotech, S.L. | Enzymatic production of cytosinic nucleoside analogues |
EP4110803A4 (en) * | 2020-02-27 | 2024-03-27 | Icahn School of Medicine at Mount Sinai | VEGFR-3 ACTIVATING AGENTS AND ONCOLYTIC VIRUSES AND THEIR USES FOR THE TREATMENT OF CANCER |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5155214A (en) * | 1984-03-05 | 1992-10-13 | The Salk Institute For Biological Studies | Basic fibroblast growth factor |
US4994559A (en) * | 1985-12-17 | 1991-02-19 | Synergen, Inc. | Human basic fibroblast growth factor |
GB8821795D0 (en) | 1988-09-16 | 1988-10-19 | Erba Carlo Spa | New derivatives of human/bovine basic fibroplast growth factor |
IT1237795B (it) * | 1989-12-22 | 1993-06-17 | Erba Carlo Spa | Fattori di crescita fibroblastici per l'uso nella prevenzione e nel trattamento di infezioni virali. |
FR2717495B1 (fr) * | 1994-03-18 | 1996-04-12 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
US6121246A (en) * | 1995-10-20 | 2000-09-19 | St. Elizabeth's Medical Center Of Boston, Inc. | Method for treating ischemic tissue |
WO1997016538A1 (fr) | 1995-10-31 | 1997-05-09 | Dnavec Research Inc. | Vecteur de virus d'arn a brin negatif possedant une activite de replication autonome |
CN1143892C (zh) * | 1995-11-01 | 2004-03-31 | 株式会社载体研究所 | 重组仙台病毒 |
US6274712B1 (en) * | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
US7226786B2 (en) * | 1999-05-18 | 2007-06-05 | Dnavec Research Inc. | Envelope gene-deficient Paramyxovirus vector |
KR20070058607A (ko) | 1999-05-18 | 2007-06-08 | 가부시키가이샤 디나벡크 겐큐쇼 | 엔벨로프 유전자 결손 파라믹소과 바이러스 벡터 |
WO2000070055A1 (fr) | 1999-05-18 | 2000-11-23 | Dnavec Research Inc. | Ribonucleoproteine derivee d'un paramyxovirus |
US20030022376A1 (en) * | 1999-05-18 | 2003-01-30 | Kaio Kitazato | Paramyxovirus-derived RNP |
US20030166252A1 (en) * | 1999-05-18 | 2003-09-04 | Kaio Kitazato | Paramyxovirus-derived RNP |
US20020169306A1 (en) * | 1999-05-18 | 2002-11-14 | Kaio Kitazato | Envelope gene-deficient paramyxovirus vector |
US7314614B1 (en) * | 1999-11-02 | 2008-01-01 | Dnavec Research, Inc. | Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
WO2001032898A2 (en) | 1999-11-02 | 2001-05-10 | Dnavec Research Inc. | Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
SE0000285D0 (sv) | 1999-12-07 | 2000-01-31 | Mika Lahtinen | Medical implant |
CA2397903A1 (en) * | 2000-01-19 | 2001-07-26 | Dnavec Research Inc. | Use of paramyxovirus vector for gene transfer into blood vessel |
CA2413995C (en) * | 2000-06-01 | 2013-08-13 | Dnavec Research Inc. | Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity |
CN1526014A (zh) * | 2000-10-06 | 2004-09-01 | ��ʽ���������о��� | 用于将外源基因导入骨骼肌的副粘病毒载体 |
JP2002142770A (ja) | 2000-11-08 | 2002-05-21 | Dnavec Research Inc | 循環系への遺伝子送達用パラミクソウイルスベクター |
AU2002224113A1 (en) * | 2000-11-27 | 2002-06-03 | Dnavec Research Inc. | Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
CN1957084A (zh) * | 2004-03-23 | 2007-05-02 | 株式会社载体研究所 | 与组织的维持和/或修复相关联的骨髓相关细胞 |
-
2001
- 2001-11-27 AU AU2002224113A patent/AU2002224113A1/en not_active Abandoned
- 2001-11-27 KR KR1020037006959A patent/KR100812884B1/ko not_active IP Right Cessation
- 2001-11-27 AT AT01997561T patent/ATE393235T1/de active
- 2001-11-27 DK DK01997561T patent/DK1344829T3/da active
- 2001-11-27 DE DE60133767T patent/DE60133767T2/de not_active Expired - Lifetime
- 2001-11-27 EP EP01997561A patent/EP1344829B1/en not_active Expired - Lifetime
- 2001-11-27 WO PCT/JP2001/010323 patent/WO2002042481A1/ja active IP Right Grant
- 2001-11-27 CA CA2430112A patent/CA2430112C/en not_active Expired - Lifetime
- 2001-11-27 JP JP2002545185A patent/JP4212357B2/ja not_active Expired - Fee Related
- 2001-11-27 CN CNB018222900A patent/CN100357443C/zh not_active Expired - Lifetime
- 2001-11-27 ES ES01997561T patent/ES2305138T3/es not_active Expired - Lifetime
-
2003
- 2003-05-23 US US10/444,661 patent/US20040005296A1/en not_active Abandoned
-
2009
- 2009-09-30 US US12/571,196 patent/US20100158867A1/en not_active Abandoned
-
2011
- 2011-03-16 US US13/049,011 patent/US8211868B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20110212059A1 (en) | 2011-09-01 |
KR20030074627A (ko) | 2003-09-19 |
JP4212357B2 (ja) | 2009-01-21 |
ATE393235T1 (de) | 2008-05-15 |
CN100357443C (zh) | 2007-12-26 |
US20100158867A1 (en) | 2010-06-24 |
JPWO2002042481A1 (ja) | 2004-03-25 |
EP1344829B1 (en) | 2008-04-23 |
ES2305138T3 (es) | 2008-11-01 |
KR100812884B1 (ko) | 2008-03-11 |
EP1344829A4 (en) | 2005-01-05 |
WO2002042481A1 (fr) | 2002-05-30 |
CA2430112A1 (en) | 2003-05-27 |
US20040005296A1 (en) | 2004-01-08 |
DE60133767T2 (de) | 2009-06-25 |
US8211868B2 (en) | 2012-07-03 |
DE60133767D1 (de) | 2008-06-05 |
DK1344829T3 (da) | 2008-09-01 |
CN1487999A (zh) | 2004-04-07 |
CA2430112C (en) | 2010-07-27 |
EP1344829A1 (en) | 2003-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002224113A1 (en) | Paramyxovirus vector encoding angiogenesis gene and utilization thereof | |
EP2329830A3 (en) | Antisense inhibition of PTP1B expression | |
EP1190099A4 (en) | ANTISENSE MODULATION OF THE P13K P85 EXPRESSION | |
WO2002092772A3 (en) | Antisense modulation of ptp1b expression | |
EP1248791A4 (en) | ANTI-SENSE MODULATION OF CASPASE 3 EXPRESSION | |
EP1248794A4 (en) | ANTISENSE MODULATION OF SMAD7 PROTEIN EXPRESSION | |
WO2003023005A3 (en) | Antisense modulation of pka regulatory subunit rii alpha expression | |
WO2002010378A3 (en) | Antisense modulation of ptp1b expression | |
WO2003023004A3 (en) | Antisense modulation of fibroblast growth factor receptor 3 expression | |
EP1189918A4 (en) | ANTISENSE MODULATION OF INTEGRIN BETA 3 EXPRESSION | |
WO2003054154A3 (en) | Antisense modulation of mucin 1, transmembrane expression | |
EP1430072A4 (en) | ANTISENSE MODULATION OF THE EXPRESSION OF THE CHOLESTERYL ESTER TRANSFER PROTEIN | |
WO2001029175A3 (en) | Antisense modulation of fra-1 expression | |
WO2002062954A3 (en) | Antisense modulation of casein kinase 2-beta expression | |
WO2002095053A3 (en) | Antisense modulation of src-c expression | |
WO2002062951A3 (en) | Antisense modulation of casein kinase 2-alpha prime expression | |
WO2001031051A3 (en) | Antisense modulation of protein kinase c-theta expression | |
WO2003012031A3 (en) | Antisense modulation of stearoyl-coa desaturase expression | |
WO2002062818A3 (en) | Antisense modulation of casein kinase 2-alpha expression | |
WO2003052062A3 (en) | Antisense modulation of cd36l1 expression | |
WO2003070878A3 (en) | Antisense modulation of hematopoietic cell protein tyrosine kinase expression | |
EP1390388A4 (en) | ANTISENSE MODULATION OF INTERFERON GAMMA RECEPTOR 1 EXPRESSION | |
WO2003044167A3 (en) | Antisense modulation of human fxr expression | |
WO2002041836A3 (en) | Antisense modulation of src-1 expression | |
WO2002040637A3 (en) | Antisense modulation of pi3k p85 expression |